Video

Dr. Musher on Immunotherapy Versus TKIs in HCC

Benjamin Leon Musher, MD, discusses immunotherapy versus TKIs in hepatocellular carcinoma.

Benjamin Leon Musher, MD, associate professor of medicine, hematology and oncology, Baylor College of Medicine, discusses immunotherapy versus TKIs in hepatocellular carcinoma.

Immunotherapy is a very hot area and patients love to think of their immune systems as being activated and attacking their cancer, says Musher. Oncologists recognized that if these drugs show activity, they may work for longer periods of time, adds Musher. However, many patients respond and sometimes tolerate TKIs better than immunotherapy. The latter does have its problems, especially if patients have compromised liver function.

Again, patients do like the idea of immunotherapy but infusions and pills are also available options, ass Musher. Some patients might be concerned about compliance with and adverse events from pills rather than immunotherapy. A realistic conversation must be had with patients to explore all available options. Good data to inform exactly which approach to use and when are not yet available, concludes Musher.

Related Videos
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on trastuzumab deruxtecan–based regimens in advanced HER2-positive GI cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on tremelimumab/durvalumab vs atezolizumab/bevacizumab in unresectable HCC.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on 5-year data for tremelimumab plus durvalumab in unresectable HCC.
Tanios Bekaii-Saab, MD, FACP
Michel Ducreux, MD, PhD, head, Gastrointestinal Oncology Unit, head, Gastrointestinal Oncology Tumor Board, Gustave Roussy; professor, oncology, Paris-Saclay University
Piotr Rutkowski, MD
Yelena Y. Janjigian, MD
Zhi Peng, MD